Michael A Gardam
Overview
Explore the profile of Michael A Gardam including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
396
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Metushi I, Zhu X, Chen X, Gardam M, Uetrecht J
Chem Res Toxicol
. 2014 Feb;
27(4):683-9.
PMID: 24564876
Isoniazid (INH) remains a mainstay for the treatment of tuberculosis despite the fact that it can cause liver failure. The mechanism of INH-induced liver injury remains controversial. It had been...
2.
Bombardier C, Hazlewood G, Akhavan P, Schieir O, Dooley A, Haraoui B, et al.
J Rheumatol
. 2012 Jun;
39(8):1583-602.
PMID: 22707613
Objective: The Canadian Rheumatology Association (CRA) has developed recommendations for the pharmacological management of rheumatoid arthritis (RA) with traditional and biologic disease-modifying antirheumatic drugs (DMARD) in 2 parts. Part II,...
3.
Hota S, Achonu C, Crowcroft N, Harvey B, Lauwers A, Gardam M
Emerg Infect Dis
. 2012 Feb;
18(2):305-7.
PMID: 22305427
To determine accuracy of measures of deaths attributable to Clostridium difficile infection, we compared 3 measures for 2007-2008 in Ontario, Canada: death certificate; death within 30 days of infection; and...
4.
Berger A, Tran A, Dedier H, Gardam M, Paige C
Life Sci
. 2009 Oct;
85(19-20):700-3.
PMID: 19800893
Aims: In this study, we examined whether hemokinin-1, the newest member of the tachykinin family and a close relative of substance P, has antimicrobial properties which have been attributed to...
5.
Gardam M, Lemieux C, Reason P, van Dijk M, Goel V
Healthc Pap
. 2009 Jul;
9(3):8-24.
PMID: 19593071
Healthcare-associated infections (HAIs) are a pressing and imminent patient safety concern as they cause substantial preventable morbidity and mortality. Despite this, there is a strong tendency for healthcare administrators and...
6.
Hota S, Hirji Z, Stockton K, Lemieux C, Dedier H, Wolfaardt G, et al.
Infect Control Hosp Epidemiol
. 2008 Dec;
30(1):25-33.
PMID: 19046054
Background: Pseudomonas aeruginosa has been increasingly recognized for its ability to cause significant hospital-associated outbreaks, particularly since the emergence of multidrug-resistant strains. Biofilm formation allows the pathogen to persist in...
7.
Achonu C, Laporte A, Gardam M
Can J Public Health
. 2005 Feb;
96(1):52-4.
PMID: 15682697
Background: Outbreaks of Severe Acute Respiratory Syndrome (SARS) in 2003 and renewed concerns regarding pandemic influenza have resulted in widespread planning for future respiratory disease outbreaks. Such planning should include...
8.
Hirji Z, Saragosa R, Dedier H, Crump M, Franke N, Burrows L, et al.
Clin Infect Dis
. 2003 May;
36(10):e115-21.
PMID: 12746790
Bacterial contamination of bone marrow or peripheral blood stem cell transplant products typically occurs with skin flora or, rarely, gram-negative organisms. We describe a clonal outbreak of contamination in transplant...
9.
Gardam M, Keystone E, Menzies R, Manners S, Skamene E, Long R, et al.
Lancet Infect Dis
. 2003 Mar;
3(3):148-55.
PMID: 12614731
Cases of active tuberculosis have been reported worldwide with the use of therapeutic agents that inhibit tumour necrosis factor (TNF) alpha. TNFalpha has a central role in mycobacterial infection and...
10.
Gardam M, Burrows L, Kus J, Brunton J, Low D, Conly J, et al.
J Infect Dis
. 2002 Nov;
186(12):1754-60.
PMID: 12447761
Multidrug-resistant enterobacteriaceae (MDRE) are an important cause of nosocomial infections. The effectiveness of screening for MDRE in the nonoutbreak setting in an attempt to prevent transmission is unknown. Patients admitted...